Insider · CIK 0001777513
Jotin Marango
Files at IMA (ImageneBio, Inc.). First filing -, latest -.
Jotin Marango files SEC Form 4 as CFO at IMA (ImageneBio, Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Jotin Marango has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 5 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jul 28, 2025 | IMA ImageneBio, Inc. | AGrant or award Common Stock | +15,776 | - | - | 15,776 | Jul 29, 2025 |
| Jul 28, 2025 | IMA ImageneBio, Inc. | FTax withholding Common Stock | -4,630 | $17.16 | $79k | 11,146 | Jul 29, 2025 |
| Jul 25, 2025 | IMA ImageneBio, Inc. | DDisposition to issuer Stock Option (Right to Buy)derivative | -181,000 | $0.00 | $0 | 0 | Jul 29, 2025 |
| Jul 25, 2025 | IMA ImageneBio, Inc. | DDisposition to issuer Stock Option (Right to Buy)derivative | -105,000 | $0.00 | $0 | 0 | Jul 29, 2025 |
| Jul 25, 2025 | IMA ImageneBio, Inc. | DDisposition to issuer Stock Option (Right to Buy)derivative | -397,199 | $0.00 | $0 | 0 | Jul 29, 2025 |
Questions about Jotin Marango
Answered from the filings on this page, as of the latest one.
Is Jotin Marango buying or selling?
Jotin Marango has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Jotin Marango's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Jotin Marango has 0.
Where does Jotin Marango file Form 4?
Jotin Marango has filed Form 4 at IMA (ImageneBio, Inc.) as Chief Financial Officer. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.